Examining the Effectiveness of Multidisciplinary Care Teams in Improving Outcomes for Breast Cancer Patients (MDCT)

Yousaf Jan

Status: Completed

Conditions: Breast Cancer Female; Breast Cancer Stage I; Breast Cancers

Treatments: Other: Standard Breast Cancer Therapy; Other: Multidisciplinary Care Team (MDCT) Approach

Study type: Interventional

Funder types: Other

Identifiers

NCT06856876

HMCKP2

Details and patient eligibility

About

To compare clinical outcomes, patient-reported measures (PROMs), and healthcare utilization between standard care with or without an MDCT in a cohort of women treated for breast cancer.

Full description

This single-center, prospective interventional trial evaluates the effectiveness of Multidisciplinary Care Teams (MDCTs) in improving outcomes for newly diagnosed breast cancer patients at Hayatabad Medical Complex, Peshawar. The study enrolled 73 participants from May 2021 to April 2024, with follow-up sessions every six months for up to two years.

Participants were randomly assigned to two groups:

Group A (n=37): Received care through MDCTs, which included radiologists, oncologists, and surgeons collaborating to create personalized treatment plans and monitor patient progress.

Group B (n=36): Received standard therapy according to existing institutional protocols.

The study assesses multiple outcomes, including **disease-free survival (DFS), overall survival (OS), recurrence rates, complication rates, patient-reported outcomes (PROs), quality of life (measured via SF-36), and healthcare utilization.

Statistical analyses include Kaplan-Meier survival curves, log-rank tests, Cox proportional hazards regression models, repeated-measures ANOVA, and linear regression models to identify predictors of survival and quality of life.

The study protocol was approved by the Institutional Review Board (IRB) and complies with the Declaration of Helsinki. All participants provided informed consent prior to enrollment.

Enrollment: 73 patients

Sex: Female

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

All female patients, diagnosed with breast cancer

Exclusion criteria

Previous treatment for breast cancer, concurrent enrollment in another clinical research, and serious medical conditions that could affect study outcomes

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

73 participants in 2 patient groups

MDCT (Group A)

Experimental group

Description:

Participants receive multidisciplinary care team (MDCT) treatment, including personalized treatment plans developed by oncologists, radiologists, and surgeons.

Treatment:

Other: Multidisciplinary Care Team (MDCT) Approach

Standard Therapy (Group B)

Active Comparator group

Description:

Participants receive standard care for breast cancer according to the current institutional protocols.

Treatment:

Other: Standard Breast Cancer Therapy